Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Respiratory eHealth company Adherium (ADR) has appointed Rick Legleiter as CEO, effective immediately
  • Current CEO and Executive Director Mike Motion has stepped down due to personal reasons but will support the company in a consulting capacity
  • Rick has more than 20 years’ experience in international healthcare and medical technology spanning across Australia, Asia, Europe and the U.S.
  • Most recently, he was CEO at Universal Biosensors (UBI) and Senior Vice President, Corporate Account Management at Siemens Healthcare
  • Adherium has also appointed George Baran as Non-Executive Director with immediate effect
  • George has over 35 years’ experience in the medical device industry and currently serves as Executive Chair of Trudell Medical
  • Adherium is down 5.88 per cent in the market and shares are trading at 1.6 cents

Respiratory eHealth company Adherium (ADR) has appointed Rick Legleiter as CEO, effective immediately.

Current CEO and Executive Director Mike Motion has stepped down due to personal reasons but will support the company in a consulting capacity.

Rick has more than 20 years’ experience in international healthcare and medical technology spanning across Australia, Asia, Europe and the U.S.

Most recently, he was CEO at Universal Biosensors (UBI) and Senior Vice President, Corporate Account Management at Siemens Healthcare.

While at UBI, Rick oversaw new product development and created an inflection point with strategic options.

“Having successfully grown laboratory diagnostics and imaging diagnostics businesses in the past, I see many parallels at Adherium working with our partners, payers and providers to grow the business and generate returns for our shareholders,” Rick stated.

Adherium has also appointed George Baran as Non-Executive Director with immediate effect.

George has over 35 years’ experience in the medical device industry and currently serves as Executive Chair of Trudell Medical.

He is also a Director of several medical device and eHealth companies such as Sky Medical Technology, Sensory Technologies and Mozzaz Corporation.

“Rick brings to the business a strong career track record of global systems business development and partnering at Siemens along with successful Australia-based CEO business turnaround performance whilst at Universal Biosensors,” Chairman James Ward-Lilley commented.

“I am also delighted to welcome George Baran to the Board, replacing Bryan Mogridge who stepped down from the Board in January,” he said.

“George brings over 35 years of medical device industry experience to the Board including business and technical leadership in the acquisition and development of novel medical device technologies,” he added.

Adherium is down 5.88 per cent in the market and shares are trading at 1.6 cents at 1:03 pm AEST.

ADR by the numbers
More From The Market Herald

" Resonance Health (ASX:RHT) contracted for third party liver disease study

Resonance Health (ASX:RHT) has been contracted to provide liver-fat quantification services for a clinical study to…

" Cann Group (ASX:CAN) granted GMP licence by TGA

Cann Group (ASX:CAN) receives a GMP licence from the Therapeutic Goods Administration (TGA) to manufacture therapeutic…
1st Group (ASX:1ST) - Managing Director, Klaus Bartosch

" 1st Group (ASX:1ST) shares rise on Visionflex acquisition

Digital health company 1st Group (ASX:1ST) was up as much as 25 per cent on the…
Atomo Diagnostics (ASX:AT1) - Managing Director, John Kelly

" Atomo Diagnostics (ASX:AT1) sees growth in cash receipts as demand for rapid antigen tests soars

Atomo Diagnostics (ASX:AT1) sees growth in cash receipts as demand for rapid antigen tests soars